ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2007

Using Natural Language Processing and Machine Learning To Identify Gout Flares From Electronic Clinical Notes

Chengyi Zheng1, Nazia Rashid2, T. Craig Cheetham3, Yi-Lin Wu3 and Gerald D. Levy4, 1Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, 2Pharmacy Analytical Services, Kaiser Permanente Southern California, Downey, CA, 3Pharmacy Analytical Services, Kaiser Permanente, Downey, CA, 4Int Med/Rheumatology, Southern California Permanente Medical Group, Downey, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: gout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Metabolic and Crystal Arthropathies II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Gout flares are the most common manifestation of gout. Gout flares are not well documented by diagnosis codes and are not adequately captured when conducting retrospective database analyses. Recently, in 2009, a code for acute gouty flare (ICD9 – 274.01) became available, but has yet to be widely adopted. We implemented a computer based method to automatically identify gout flares using Natural Language Processing (NLP) and Machine Learning (ML). NLP aims to understand human languages and facilitates the utilization of the information in the free text. Machine Learning is aimed to train a computer system from data and then used to make decisions on new data.

Methods:

A retrospective review was conducted between 1/1/2007 to 12/31/2010 from Kaiser Permanente Southern California Region. Patients > 18 years, with a diagnosis of gout (ICD9 274.xx) and on urate-lowering therapy were identified. 599,317 notes for 16,519 patients were retrieved. A training dataset of 1,264 notes was created by selecting 100 random patients. A Rheumatologist reviewed these notes to classify each note as gout flare or not. 1,192 notes from another 100 random selected patients were created and independently reviewed by two Rheumatologists to create the gold standard. A list of key words and phrases were used in the NLP algorithm which was used to capture different aspects of gout flares. The NLP results were used as features of the ML system which helped to achieve better specificity without significant loss in sensitivity. Both NLP+ML algorithms were developed using the training dataset then applied to all of the notes. Gout flares were also identified using claims data as proposed in published literature, which was then compared to the gold standard as well.

Results:

Out of the 599,317 notes, the NLP system identified 49,415 notes as gout flare. ML system further classified them into 18,869 positive and 30,546 negative cases. Flares occurred within 30 days are merged. For the 16,519 patients, the NLP+ML system identified 1,402 patients with >= 3 flares, 5,954 with 1-2 flares, and 9,163 with no flare. Our method significantly identified more flare cases (18,869 vs. 7,861) and patients (7,356 vs. 5,458) compared to the method using the claims data.

On task of identifying flare for each note, our method achieved sensitivity of 84.8% and specificity of 92.2%. On task of identifying patients who had flares, our method had sensitivity of 98.5% and specificity of 96.4%. On task of identifying patients who had 3 or more flares, our method had sensitivity of 93.5% and specificity of 84.6%. The NLP+ML method is consistently better than the claims data approach and it even out-performed the two rheumatologist reviewers on task of identifying patients with gout flares.

 

Conclusion:

A combination of NLP and ML is able to accurately and efficiently identify patients with gout flares. This is the first successful use of a computer controlled algorithm to identify gout flares from the clinical notes. It demonstrates that NLP could be a valuable tool to identify populations of patients who experience gout flares for more intensive therapy, ultimately getting them to serum urate goal, and help reducing overall costs associated to gout flares.


Disclosure:

C. Zheng,
None;

N. Rashid,
None;

T. C. Cheetham,
None;

Y. L. Wu,
None;

G. D. Levy,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-natural-language-processing-and-machine-learning-to-identify-gout-flares-from-electronic-clinical-notes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology